Franklin Stuart Friedman is of Deciphera Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of DCPH, which is worth approximately $0. The most recent transaction as insider was on Jun 11, 2024, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Franklin Stuart Friedman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2024
SELL
Disposition due to a tender of shares in a change of control transaction
-
10,000 Reduced 100.0%
0 Common Stock
Jun 08 2023
BUY
Open market or private purchase
$138,800 $13.88 p/Share
10,000 Added 50.0%
10,000 Common Stock
FSF

Franklin Stuart Friedman

Waltham, MA

Track Institutional and Insider Activities on DCPH

Follow Deciphera Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DCPH shares.

Notify only if

Insider Trading

Get notified when an Deciphera Pharmaceuticals, Inc. insider buys or sells DCPH shares.

Notify only if

News

Receive news related to Deciphera Pharmaceuticals, Inc.

Track Activities on DCPH